Surgical LAA closure: Why, When and How

Activity Description

This activity features expert presentations that investigate current challenges and further evolutions in surgical LAA Closure procedures to optimally manage complex Atrial Fibrillation patients. The distinguished faculty reviews the role of the left atrial appendage in systemic thromboembolism, assess the impact of LAA Occlusion for stroke prophylaxis, examine successful clinical implementation of LAA occlusion within daily practice, and analyze the procedures economic benefits.

Access Presentation

Webcast

Click on the session title listed below to view each presentation.

	Opening Remarks Marc Gerdisch, MD, FACS, FACC
	Efficacy of Surgical LAA Exclusion John Stulak, MD
	Thoracoscopic LAA Closure, with and without Lesions Gan Dunnington, MD
	The Impact of Surgical LAA Closure: Risk and Mortality Manuel Wilbring, MD
	Panel Discussion *Moderator:* Marc Gerdisch, MD, FACS, FACC Panel: Gan Dunnington, MD, John Stulak, MD, and Manuel Wilbring, MD

Commercial Supporter

This activity is supported by an educational grant from AtriCure

Sponsor

MediaSphere Medical, LLC

Faculty

Program Chair

Marc Gerdisch, MD, FACS, FACC
Cardiac Surgery Associates
Chief of Cardiovascular and Thoracic Surgery
Franciscan St Francis Heart Center
Indianapolis, IN

Faculty

	Gan H. Dunnington Jr., MD Director of Arrhythmia Center Adventist Heart Institute St. Helena Hospital St. Helena, CA
	John M. Stulak, MD Associate Professor of Surgery Consultant, Department of Cardiovascular Surgery Mayo Clinic College of Medicine Rochester, MN
	Manuel Wilbring, MD Department of Cardiac Surgery Comprehensive Heart Center University Hospital Halle (Saale) Halle (Saale), Germany